Bioendo Participates in the 19th Academic Annual Conference
Advancing Sustainable Endotoxin Testing Solutions and Industry Collaboration
The 19th Academic Annual Conference of the Drug Inspection and Pharmacology Professional Committee of the Chinese Pharmacological Society was successfully concluded on November 10, 2023. The conference was jointly organized by the Drug Inspection and Pharmacology Professional Committee, the Chinese Pharmacological Bulletin, and the Chinese Journal of Modern Applied Pharmacy, and hosted by the Hubei Institute for Drug Control.
Xiamen Bioendo Technology Co., Ltd. ("Bioendo"), one of the organizations involved in the development of the group standard for horseshoe crab reagents, was invited to participate in the conference. The event brought together experts and professionals from drug inspection institutions, pharmaceutical research organizations, academia, and industry to exchange insights on pharmaceutical testing, pharmacology, and new drug development.
During the conference, experts and representatives from drug inspection institutes across China delivered presentations on the latest developments in pharmaceutical testing and pharmacology. The discussions provided valuable perspectives on industry trends, scientific innovation, and the advancement of new drug development, while creating opportunities for technical exchange and collaboration among professionals from different fields.
During the conference, Bioendo presented its comprehensive sustainable endotoxin testing solutions, highlighting the company's 45-year commitment to horseshoe crab reagent and endotoxin testing technologies.
Over the past 45 years, Bioendo has continuously expanded its capabilities across the endotoxin testing workflow. Today, the company's portfolio has evolved beyond traditional reagents into an integrated solution covering testing reagents, detection instruments, professional software, recombinant reagents, fully automated intelligent robotic systems, and complete 3Q validation solutions .
This integrated approach reflects Bioendo's commitment to providing laboratories with more efficient, reliable, and sustainable solutions for modern endotoxin testing and quality control.
On the morning of November 10, Bioendo also participated in a dedicated workshop on the development of the group standard for horseshoe crab reagents. The workshop brought together members and experts of the Drug Inspection and Pharmacology Professional Committee of the Chinese Pharmacological Society, technical professionals from food and drug inspection and testing institutions, as well as representatives from enterprises, universities, and research organizations.
Through technical discussions and professional exchange, participants shared their expertise and perspectives on the development of standards for horseshoe crab reagents, contributing to the continued advancement and standardization of endotoxin testing practices.
As the endotoxin testing industry continues to evolve, Bioendo will remain committed to technological innovation, industry collaboration, and the development of sustainable testing solutions. By combining decades of experience with recombinant technologies, automation, and intelligent laboratory solutions, Bioendo continues to support laboratories and pharmaceutical manufacturers in meeting the evolving requirements of modern quality control.